{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T19:04:47Z","timestamp":1775329487723,"version":"3.50.1"},"reference-count":71,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2013,5,20]],"date-time":"2013-05-20T00:00:00Z","timestamp":1369008000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0063644","type":"journal-article","created":{"date-parts":[[2013,5,20]],"date-time":"2013-05-20T21:10:07Z","timestamp":1369084207000},"page":"e63644","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":394,"title":["Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer\u2019s Disease Using Metabolomics"],"prefix":"10.1371","volume":"8","author":[{"given":"Eugenia","family":"Trushina","sequence":"first","affiliation":[]},{"given":"Tumpa","family":"Dutta","sequence":"additional","affiliation":[]},{"given":"Xuan-Mai T.","family":"Persson","sequence":"additional","affiliation":[]},{"given":"Michelle M.","family":"Mielke","sequence":"additional","affiliation":[]},{"given":"Ronald C.","family":"Petersen","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2013,5,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nature02264","article-title":"Folding proteins in fatal ways","volume":"426","author":"DJ Selkoe","year":"2003","journal-title":"Nature"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1038\/nm1067","article-title":"Molecular pathways to neurodegeneration","volume":"10","author":"E Bossy-Wetzel","year":"2004","journal-title":"Nature medicine"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade","volume":"9","author":"CR Jack Jr","year":"2010","journal-title":"Lancet neurology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"77sr71","DOI":"10.1126\/scitranslmed.3002369","article-title":"Alzheimer\u2019s disease: the challenge of the second century","volume":"3","author":"DM Holtzman","year":"2011","journal-title":"Science translational medicine"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease","volume":"367","author":"RJ Bateman","year":"2012","journal-title":"The New England journal of medicine"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Fleisher AS, Chen K, Quiroz YT, Jakimovich LJ, Gomez MG, <etal>et al<\/etal>.. (2012) Florbetapir PET analysis of amyloid-beta deposition in the presenilin 1 E280A autosomal dominant Alzheimer\u2019s disease kindred: a cross-sectional study. Lancet neurology.","DOI":"10.1016\/S1474-4422(12)70227-2"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1474-4422(12)70142-4","article-title":"Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-beta plaques: a prospective cohort study","volume":"11","author":"CM Clark","year":"2012","journal-title":"Lancet neurology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1001\/archneurol.2012.90","article-title":"Effect of Immunotherapy With Bapineuzumab on Cerebrospinal Fluid Biomarker Levels in Patients With Mild to Moderate Alzheimer Disease","volume":"69","author":"K Blennow","year":"2012","journal-title":"Archives of neurology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/archneurol.2011.1538","article-title":"Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab","volume":"69","author":"S Ostrowitzki","year":"2012","journal-title":"Archives of neurology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1474-4422(10)70043-0","article-title":"11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer\u2019s disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study","volume":"9","author":"JO Rinne","year":"2010","journal-title":"Lancet neurology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrd2176","article-title":"Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics","volume":"6","author":"LM Shaw","year":"2007","journal-title":"Nature reviews Drug discovery"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Ansari N, Khodagholi F (2012) Molecular mechanism aspect of ER stress in Alzheimer\u2019s disease: Current approaches and future strategies. Current drug targets.","DOI":"10.2174\/1389450111314010012"},{"key":"ref13","first-page":"752894","article-title":"Lysosomal fusion dysfunction as a unifying hypothesis for Alzheimer\u2019s disease pathology","volume":"2012","author":"KE Funk","year":"2012","journal-title":"International journal of Alzheimer\u2019s disease"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1124\/jpet.112.192138","article-title":"Mitochondrial dysfunction in neurodegenerative diseases","volume":"342","author":"A Johri","year":"2012","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3233\/JAD-2010-100129","article-title":"Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE epsilon4 allele, the major late-onset Alzheimer\u2019s susceptibility gene","volume":"22","author":"J Valla","year":"2010","journal-title":"Journal of Alzheimer\u2019s disease : JAD"},{"key":"ref16","first-page":"24","article-title":"Lipoproteins and lipid peroxidation in Alzheimer\u2019s disease","volume":"7","author":"CN Bassett","year":"2003","journal-title":"The journal of nutrition, health & aging"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.bbalip.2010.01.010","article-title":"Multi-dimensional mass spectrometry-based shotgun lipidomics and the altered lipids at the mild cognitive impairment stage of Alzheimer\u2019s disease","volume":"1801","author":"X Han","year":"2010","journal-title":"Biochimica et biophysica acta"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e21643","DOI":"10.1371\/journal.pone.0021643","article-title":"Metabolomics in early Alzheimer\u2019s disease: identification of altered plasma sphingolipidome using shotgun lipidomics","volume":"6","author":"X Han","year":"2011","journal-title":"PLoS One"},{"key":"ref19","first-page":"459806","article-title":"Alterations in Lipid Levels of Mitochondrial Membranes Induced by Amyloid-beta: A Protective Role of Melatonin","volume":"2012","author":"SA Rosales-Corral","year":"2012","journal-title":"International journal of Alzheimer\u2019s disease"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease","volume":"6","author":"K Blennow","year":"2010","journal-title":"Nature reviews Neurology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.brainresrev.2009.05.003","article-title":"Plasma biomarkers for mild cognitive impairment and Alzheimer\u2019s disease","volume":"61","author":"F Song","year":"2009","journal-title":"Brain research reviews"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.neurobiolaging.2005.06.005","article-title":"Cerebrospinal fluid tau and beta-amyloid in Alzheimer patients, disease controls and an age-matched random sample","volume":"27","author":"B Ibach","year":"2006","journal-title":"Neurobiology of aging"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.exger.2009.09.008","article-title":"Biomarkers for Alzheimer\u2019s disease and other forms of dementia: clinical needs, limitations and future aspects","volume":"45","author":"A Cedazo-Minguez","year":"2010","journal-title":"Experimental gerontology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrm3314","article-title":"Innovation: Metabolomics: the apogee of the omics trilogy","volume":"13","author":"GJ Patti","year":"2012","journal-title":"Nature reviews Molecular cell biology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e32737","DOI":"10.1371\/journal.pone.0032737","article-title":"Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer\u2019s disease","volume":"7","author":"E Trushina","year":"2012","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jalz.2010.06.001","article-title":"Metabolomic changes in autopsy-confirmed Alzheimer\u2019s disease","volume":"7","author":"R Kaddurah-Daouk","year":"2011","journal-title":"Alzheimer\u2019s & dementia : the journal of the Alzheimer\u2019s Association"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nchembio.767","article-title":"Metabolomics implicates altered sphingolipids in chronic pain of neuropathic origin","volume":"8","author":"GJ Patti","year":"2012","journal-title":"Nature chemical biology"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Ibanez C, Simo C, Martin-Alvarez PJ, Kivipelto M, Winblad B, <etal>et al<\/etal>.. (2012) Toward a Predictive Model of Alzheimer\u2019s Disease Progression Using Capillary Electrophoresis-Mass Spectrometry Metabolomics. Analytical chemistry.","DOI":"10.1021\/ac301243k"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1194\/jlr.M022376","article-title":"Identification of a new plasma biomarker of Alzheimer\u2019s disease using metabolomics technology","volume":"53","author":"Y Sato","year":"2012","journal-title":"Journal of lipid research"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e31501","DOI":"10.1371\/journal.pone.0031501","article-title":"Metabolite profiling of Alzheimer\u2019s disease cerebrospinal fluid","volume":"7","author":"C Czech","year":"2012","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1038\/tp.2011.55","article-title":"Metabolome in progression to Alzheimer\u2019s disease","volume":"1","author":"M Oresic","year":"2011","journal-title":"Translational psychiatry"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000115751","article-title":"The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics","volume":"30","author":"RO Roberts","year":"2008","journal-title":"Neuroepidemiology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"RC Petersen","year":"2004","journal-title":"Journal of internal medicine"},{"key":"ref34","unstructured":"Association AP (1994) Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington, D.C.: American Psychiatric Association."},{"key":"ref35","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"G McKhann","year":"1984","journal-title":"Neurology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.2337\/db11-0874","article-title":"Concordance of changes in metabolic pathways based on plasma metabolomics and skeletal muscle transcriptomics in type 1 diabetes","volume":"61","author":"T Dutta","year":"2012","journal-title":"Diabetes"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1021\/ac702089h","article-title":"Practical approach for the identification and isomer elucidation of biomarkers detected in a metabonomic study for the discovery of individuals at risk for diabetes by integrating the chromatographic and mass spectrometric information","volume":"80","author":"J Chen","year":"2008","journal-title":"Analytical chemistry"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11306-010-0218-7","article-title":"Metabolomic and transcriptomic analysis of the rice response to the bacterial blight pathogen Xanthomonas oryzae pv. oryzae","volume":"6","author":"TR Sana","year":"2010","journal-title":"Metabolomics : Official journal of the Metabolomic Society"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1093\/bioinformatics\/btq307","article-title":"Large-scale benchmark of Endeavour using MetaCore maps","volume":"26","author":"S Schuierer","year":"2010","journal-title":"Bioinformatics"},{"key":"ref40","unstructured":"Eriksson L, Johansson E., Kettaneh-Wold N., Wold S (2001) Milti-and megavariate data analysis principals and applications. Umea, Sweden: Umetrics."},{"key":"ref41","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer\u2019s disease is a synaptic failure","volume":"298","author":"DJ Selkoe","year":"2002","journal-title":"Science"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pneurobio.2012.06.010","article-title":"The serotonergic system in ageing and Alzheimer\u2019s disease","volume":"99","author":"JJ Rodriguez","year":"2012","journal-title":"Progress in neurobiology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0006-8993(90)91761-5","article-title":"Serotonin release varies with brain tryptophan levels","volume":"532","author":"JD Schaechter","year":"1990","journal-title":"Brain research"},{"key":"ref44","first-page":"493","article-title":"The mammalian pineal as a neuroendocrine transducer","volume":"25","author":"RJ Wurtman","year":"1969","journal-title":"Recent progress in hormone research"},{"key":"ref45","first-page":"1395","article-title":"Studies on the Biosynthesis of Nicotinamide Adenine Dinucleotide. Ii. A Role of Picolinic Carboxylase in the Biosynthesis of Nicotinamide Adenine Dinucleotide from Tryptophan in Mammals","volume":"240","author":"M Ikeda","year":"1965","journal-title":"The Journal of biological chemistry"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1176\/appi.ajp.161.6.1096","article-title":"Neuropathological study of the dorsal raphe nuclei in late-life depression and Alzheimer\u2019s disease with and without depression","volume":"161","author":"M Hendricksen","year":"2004","journal-title":"The American journal of psychiatry"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"843649","DOI":"10.1155\/2012\/843649","article-title":"Accumulation of exogenous amyloid-beta peptide in hippocampal mitochondria causes their dysfunction: a protective role for melatonin","volume":"2012","author":"S Rosales-Corral","year":"2012","journal-title":"Oxidative medicine and cellular longevity"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-079X.2011.00864.x","article-title":"Melatonin treatment restores mitochondrial function in Alzheimer\u2019s mice: a mitochondrial protective role of melatonin membrane receptor signaling","volume":"51","author":"N Dragicevic","year":"2011","journal-title":"Journal of pineal research"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00726-006-0409-8","article-title":"Free amino acid and dipeptide changes in the body fluids from Alzheimer\u2019s disease subjects","volume":"32","author":"AN Fonteh","year":"2007","journal-title":"Amino acids"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0006-3223(99)00232-2","article-title":"The role of norepinephrine in the pathophysiology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer\u2019s disease","volume":"46","author":"JI Friedman","year":"1999","journal-title":"Biological psychiatry"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1212\/WNL.32.2.164","article-title":"Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia","volume":"32","author":"W Bondareff","year":"1982","journal-title":"Neurology"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3940(95)11881-V","article-title":"Brain polyamine levels are altered in Alzheimer\u2019s disease","volume":"197","author":"LD Morrison","year":"1995","journal-title":"Neuroscience letters"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0006-291X(66)90415-3","article-title":"Enzymatic synthesis of diadenosine tetraphosphate and diadenosine triphosphate with a purified lysyl-sRNA synthetase","volume":"24","author":"PC Zamecnik","year":"1966","journal-title":"Biochemical and biophysical research communications"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0014-5793(98)00560-2","article-title":"The neurotransmitter role of diadenosine polyphosphates","volume":"430","author":"MT Miras-Portugal","year":"1998","journal-title":"FEBS letters"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0014-5793(98)00114-8","article-title":"Diadenosine 5\u2032,5\u2032\u2032-P1,P5-pentaphosphate harbors the properties of a signaling molecule in the heart","volume":"423","author":"A Jovanovic","year":"1998","journal-title":"FEBS letters"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1124\/jpet.103.061564","article-title":"GABA modulates presynaptic signalling mediated by dinucleotides on rat synaptic terminals","volume":"308","author":"R Gomez-Villafuertes","year":"2004","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00401-011-0921-0","article-title":"Neurodegeneration as a consequence of failed mitochondrial maintenance","volume":"123","author":"M Karbowski","year":"2012","journal-title":"Acta neuropathologica"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.bbadis.2011.10.011","article-title":"Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer\u2019s disease: Implications to mitochondria-targeted antioxidant therapeutics","volume":"1822","author":"PH Reddy","year":"2012","journal-title":"Biochimica et biophysica acta"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1089\/ars.2011.4400","article-title":"Insights into mitochondrial dysfunction: aging, amyloid-beta, and tau-A deleterious trio","volume":"16","author":"K Schmitt","year":"2012","journal-title":"Antioxidants & redox signaling"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Selfridge JE, E L, Lu J, Swerdlow RH (2012) Role of mitochondrial homeostasis and dynamics in Alzheimer\u2019s disease. Neurobiology of Disease.","DOI":"10.1016\/j.nbd.2011.12.057"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.mam.2011.10.005","article-title":"Shift in brain metabolism in late onset Alzheimer\u2019s disease: implications for biomarkers and therapeutic interventions","volume":"32","author":"J Yao","year":"2011","journal-title":"Molecular aspects of medicine"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s11306-010-0203-1","article-title":"Metabonomic fingerprints of fasting plasma and spot urine reveal human pre-diabetic metabolic traits","volume":"6","author":"X Zhao","year":"2010","journal-title":"Metabolomics : Official journal of the Metabolomic Society"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1194\/jlr.C400004-JLR200","article-title":"Rapid quantification of free and esterified phytosterols in human serum using APPI-LC-MS\/MS","volume":"46","author":"J Lembcke","year":"2005","journal-title":"Journal of lipid research"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0076-6879(07)32006-5","article-title":"Extraction and analysis of sterols in biological matrices by high performance liquid chromatography electrospray ionization mass spectrometry","volume":"432","author":"JG McDonald","year":"2007","journal-title":"Methods in enzymology"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0022-2275(20)31643-6","article-title":"Sterols in blood of normal and Smith-Lemli-Opitz subjects","volume":"42","author":"B Ruan","year":"2001","journal-title":"Journal of lipid research"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1023\/A:1027380331807","article-title":"Membrane phospholipid alterations in Alzheimer\u2019s disease: deficiency of ethanolamine plasmalogens","volume":"22","author":"AA Farooqui","year":"1997","journal-title":"Neurochemical research"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1749-6632.2012.06513.x","article-title":"The link between altered cholesterol metabolism and Alzheimer\u2019s disease","volume":"1259","author":"P Gamba","year":"2012","journal-title":"Annals of the New York Academy of Sciences"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3233\/JAD-2011-110405","article-title":"Plasma sphingomyelins are associated with cognitive progression in Alzheimer\u2019s disease","volume":"27","author":"MM Mielke","year":"2011","journal-title":"Journal of Alzheimer\u2019s disease : JAD"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0090-6980(02)00031-X","article-title":"Prostaglandins and other lipid mediators in Alzheimer\u2019s disease","volume":"68\u201369","author":"NG Bazan","year":"2002","journal-title":"Prostaglandins & other lipid mediators"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/jnnp.2005.063131","article-title":"Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer\u2019s disease","volume":"77","author":"M Combrinck","year":"2006","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1042\/BST0331041","article-title":"Increased risk of Alzheimer\u2019s disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology?","volume":"33","author":"GJ Biessels","year":"2005","journal-title":"Biochemical Society transactions"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0063644","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T12:53:20Z","timestamp":1645102400000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0063644"}},"subtitle":[],"editor":[{"given":"Elliot","family":"Mufson","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2013,5,20]]},"references-count":71,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,5,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0063644","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,20]]}}}